Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine in Diabetic Kidney Disease
NCT05638880Phase 2Completed
- Start
- Dec 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocetirizine in diabetic nephropathy (DN). Started Dec 2022; status: completed.
02
Drugs
levocetirizine
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT05638880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05638880.